These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 18538839

  • 1. Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases.
    Santana-Davila R, Tefferi A, Holtan SG, Ketterling RP, Dewald GW, Knudson RA, Steensma DP, Chen D, Hoyer JD, Hanson CA.
    Leuk Res; 2008 Dec; 32(12):1927-30. PubMed ID: 18538839
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased Dkk3 protein expression in platelets and megakaryocytes of patients with myeloproliferative neoplasms.
    Medinger M, Tzankov A, Kern J, Pircher A, Hermann M, Ott HW, Gastl G, Untergasser G, Gunsilius E.
    Thromb Haemost; 2011 Jan; 105(1):72-80. PubMed ID: 20978717
    [Abstract] [Full Text] [Related]

  • 4. Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution.
    Santana-Davila R, Holtan SG, Dewald GW, Ketterling RP, Knudson RA, Hanson CA, Steensma DP, Tefferi A.
    Leuk Res; 2008 Mar; 32(3):407-11. PubMed ID: 17707907
    [Abstract] [Full Text] [Related]

  • 5. [The morphology features of bone marrow in the prefibrotic-early primary myelofibrosis].
    Gong XB, Zhang XH, Lu XG, Tang QS, Gao X, Yang J.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):25-30. PubMed ID: 22575188
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Karyotype findings and molecular analysis of the bcr gene rearrangement supplementing the histologic classification of chronic myeloproliferative disorders.
    Werner M, Nolte M, Kaloutsi V, Buhr T, Kausche F, Georgii A.
    Lab Invest; 1995 Apr; 72(4):405-10. PubMed ID: 7723278
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Polycythemia vera evolving into a rapidly progressive Ph-negative del(5q)-positive myeloproliferative neoplasm refractory to lenalidomide.
    Dasanu CA, Schwartz RA, Bauer F, Davis LK, Silver JS, Reale MA.
    Leuk Res; 2011 May; 35(5):e41-3. PubMed ID: 21288571
    [No Abstract] [Full Text] [Related]

  • 10. Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: a computer-assisted image analysis study.
    Ahmed A, Powers MP, Youker KA, Rice L, Ewton A, Dunphy CH, Chang CC.
    Pathol Res Pract; 2009 May; 205(9):634-8. PubMed ID: 19446406
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis.
    Florena AM, Tripodo C, Di Bernardo A, Iannitto E, Guarnotta C, Porcasi R, Ingrao S, Abbadessa V, Franco V.
    J Clin Pathol; 2009 Apr; 62(4):331-8. PubMed ID: 19329711
    [Abstract] [Full Text] [Related]

  • 13. [Clinicopathologic conference. Chronic myeloproliferative disease with an increase in platelet count in the differential diagnosis of primary (essential, idiopathic) thrombocythemia (PTH)].
    Zankovich R, Thiele J, Fischer R, Diehl V.
    Med Klin (Munich); 1986 Jan 17; 81(1):31-5. PubMed ID: 3785010
    [No Abstract] [Full Text] [Related]

  • 14. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.
    Barbui T, Thiele J, Passamonti F, Rumi E, Boveri E, Ruggeri M, Rodeghiero F, d'Amore ES, Randi ML, Bertozzi I, Marino F, Vannucchi AM, Antonioli E, Carrai V, Gisslinger H, Buxhofer-Ausch V, Müllauer L, Carobbio A, Gianatti A, Gangat N, Hanson CA, Tefferi A.
    J Clin Oncol; 2011 Aug 10; 29(23):3179-84. PubMed ID: 21747083
    [Abstract] [Full Text] [Related]

  • 15. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R, Marzetta K, Miglioranza A, Redaelli S, Maino C, Maffiolini A, Gorini M.
    Recenti Prog Med; 2003 Aug 10; 94(7-8):314-20. PubMed ID: 12868237
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes].
    Bock O.
    Verh Dtsch Ges Pathol; 2007 Aug 10; 91():140-53. PubMed ID: 18314608
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.